ICD-10 Coding for Glioblastoma(C71.0, C71.0B, C71.0M)
Comprehensive guide on ICD-10 coding for glioblastoma, including code ranges, documentation requirements, and billing considerations.
Complete code families applicable to Glioblastoma
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| C71.0 | Malignant neoplasm of cerebrum, except lobes and ventricles | Use when glioblastoma is located in the frontal lobe. |
|
| C71.9 | Malignant neoplasm of brain, unspecified | Use when the location of glioblastoma is not specified. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutGlioblastoma
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Glioblastoma.
Failing to document IDH status
Impact
Clinical: Impacts treatment decisions and prognosis., Regulatory: May lead to coding inaccuracies., Financial: Affects reimbursement if coding is incorrect.
Mitigation
Ensure IDH status is included in pathology reports.
Using C71.9 when a specific location is documented
Impact
Reimbursement: May lead to incorrect DRG assignment affecting reimbursement., Compliance: Increases risk of audit due to lack of specificity., Data Quality: Reduces accuracy of clinical data.
Mitigation
Review imaging and pathology reports to ensure specific location is coded.
Specificity of tumor location
Impact
Audits may focus on the specificity of tumor location in documentation.
Mitigation
Regularly review and update documentation practices to ensure location specificity.